Validation of metabolomic models for prediction of early-onset preeclampsia
- 1 October 2015
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 213 (4) , 530.e1-530.e10
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset diseaseAmerican Journal of Obstetrics and Gynecology, 2013
- The Metabolomic Profile of Umbilical Cord Blood in Neonatal Hypoxic Ischaemic EncephalopathyPLOS ONE, 2012
- Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular DiseasesCirculation, 2012
- Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-AnalysisFetal Diagnosis and Therapy, 2012
- Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeksPrenatal Diagnosis, 2011
- Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsiaJournal of Perinatal Medicine, 2011
- Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early PregnancyObstetrics & Gynecology, 2010
- Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeksUltrasound in Obstetrics & Gynecology, 2009
- Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsiaPrenatal Diagnosis, 2009
- Metabolomic profiling to develop blood biomarkers for Parkinson's diseaseBrain, 2008